4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-18-023122
Chief Operating Officer sold 482 shares at $0.50 ($242)
From the SEC's structured data for this filing
Trades in this filing
Keuer Thomas A · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-04-03 | Sale : show line 1 in the form | −482 | $0.50 | $242 | 13,153 | D |
| Open-market sales · 482 sh · avg $0.50 · $242 | ||||||
Loading xslF345X03/doc4.xml…